Cannabis
HempWave Announces Agreements to Grow & Harvest Over 600 Acres of Industrial Hemp in Arizona and Estimates 2.1 million pounds of hemp biomass in 2019
HempWave today announced it has entered into agreements with four large-scale farming operations in Arizona, agreements that will allow it to grow and harvest industrial hemp on over 600 acres in 2019.
Based upon these new growing and harvesting agreements, as well as its previously announced acquisition of two Arizona-based greenhouses totaling 210,000 square feet of space for commercial hemp nursery operations, HempWave estimates that it will produce 2.1 million pounds of hemp biomass in 2019 alone, which at current market rates of $25/lb if sold in its raw form, would have a market value of $52.5 million.
Since its formation in 2018, HempWave has moved aggressively to take full advantage of the widespread interest in industrial hemp. HempWave’s four initial commercial hemp farms will be based in Arizona’s Gila River Valley, as well as in the cities of Eloy and Willcox.
According to HempWave Chief Executive Officer, David Soto, Arizona’s climate and legal structure make it an ideal locale for the company’s business.
“Arizona is an excellent location for becoming one of the country’s premier industrial hemp companies, both legally and from an environmental standpoint,” Soto said. “We applaud Arizona’s governor and our legislature for moving so quickly to help Arizona businesses move to the forefront of the unfolding industrial hemp revolution. And we look forward to working with other farmers and landowners throughout the state and around the country to meet the explosive demand for commercial hemp products ranging from legal cannabidoils and CBDs to hemp-based fabrics and building materials.”
Hemp: The Miracle Plant
For thousands of years, humans have cultivated and harvested what is today known as industrial hemp, especially for use as fabric, twines and rope. In fact, industrial hemp was the main source for rope used by the United States military during World War II.
Although a close cousin to marijuana (and in spite of the misperceptions of many individuals), hemp contains only miniscule amounts of tetrahydrocannabinol — (also known as THC) — the psychoactive chemical compound found in marijuana that gets users “high.”
In reality, any Cannabis Sativa L. plant containing more than 0.3 percent of THC is legally identified as marijuana, a Schedule 1 drug, while industrial hemp is limited to THC levels of 0.3 percent or lower. {This distinction was laid out in the Agriculture Improvement Act of 2018 (aka, the 2018 Farm Bill) and became effective when it was signed into law on December 20, 2018.}
Conversely, commercial hemp can be optimized for producing high levels of cannabidoils and CBDs, compounds that a growing body of clinical research and anecdotal evidence suggest deliver a wide variety of medicinal benefits, including treatments for pain, sleep apnea, movement disorders, cognition, anxiety, and other maladies. In addition, most parts of the hemp plant can be used for a variety of non-medicinal applications.
SOURCE HempWave
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan1 week ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf1 week ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE3 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis2 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace